GT200000114A - Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida. - Google Patents

Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida.

Info

Publication number
GT200000114A
GT200000114A GT200000114A GT200000114A GT200000114A GT 200000114 A GT200000114 A GT 200000114A GT 200000114 A GT200000114 A GT 200000114A GT 200000114 A GT200000114 A GT 200000114A GT 200000114 A GT200000114 A GT 200000114A
Authority
GT
Guatemala
Prior art keywords
phenyl
crystalline form
form iii
dimethylaminoftalen
sulphonylamine
Prior art date
Application number
GT200000114A
Other languages
English (en)
Inventor
Alfonso Grunenberg
Andreas Lender
Andree Folkerts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000114A publication Critical patent/GT200000114A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A LA FORMA CRISTALINA III DE LA N(4(5DIMETILAMINONAFTALEN1SULFONILAMINO)FENIL)3 HIDROXI2, 2DIMETILPROPIONAMIDA (REFERIDA EN ADELANTE COMO DNSP), COMPRENDE PROCEDIMIENTOS PARA SU OBTENCION, A FORMULACIONES DE MEDICAMENTOS QUE LA COMPRENDEN Y A SU USO PARA EL TRATAMIENTO O PROFILAXIS DE INFECCIONES VIRICAS Y ENFERMEDADES CAUSADAS POR ESTOS, ESPECIALMENTE PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES CAUSADAS POR CITOMEGALOVIRUS HUMANO (HCMV).
GT200000114A 1999-07-21 2000-07-10 Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida. GT200000114A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934295A DE19934295A1 (de) 1999-07-21 1999-07-21 Kristallmodifikation III von N-(4-(5-Dimethylamino-naphthalin-1-sulfonyl-amino)-phenyl)-3-hydroxy-2,2-dimethyl-propionamid

Publications (1)

Publication Number Publication Date
GT200000114A true GT200000114A (es) 2002-01-01

Family

ID=7915608

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000114A GT200000114A (es) 1999-07-21 2000-07-10 Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida.

Country Status (8)

Country Link
AR (1) AR024797A1 (es)
AU (1) AU6562600A (es)
CO (1) CO5180571A1 (es)
DE (1) DE19934295A1 (es)
GT (1) GT200000114A (es)
PE (1) PE20010382A1 (es)
UY (1) UY26251A1 (es)
WO (1) WO2001007404A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780794B2 (en) 2000-01-20 2004-08-24 Honeywell International Inc. Methods of bonding physical vapor deposition target materials to backing plate materials
US6698647B1 (en) 2000-03-10 2004-03-02 Honeywell International Inc. Aluminum-comprising target/backing plate structures
US7371906B2 (en) 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP2481540B1 (de) 2011-01-28 2017-11-01 Schelling Anlagenbau GmbH Einrichtung zum Zersägen von zumindest zwei platten- oder plattenstapelförmigen Werkstücken

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL341815A1 (en) * 1998-01-23 2001-05-07 Bayer Ag Novel naphtyl- and anilide-susbtituted sulphonamides

Also Published As

Publication number Publication date
WO2001007404A1 (de) 2001-02-01
AR024797A1 (es) 2002-10-23
AU6562600A (en) 2001-02-13
CO5180571A1 (es) 2002-07-30
DE19934295A1 (de) 2001-01-25
UY26251A1 (es) 2001-01-31
PE20010382A1 (es) 2001-06-11

Similar Documents

Publication Publication Date Title
ECSP003589A (es) Compuestos organicos
BRPI0411900B8 (pt) compostos e composições farmacêuticas compreendendo os mesmos
HRP20060254A2 (en) Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
NO20052512L (no) Purinforbindelser og anvendelse deav som kannabinoiode reseptorligander
PA8578601A1 (es) Derivados de 2,2- difenil-benzodioxol
ECSP024399A (es) Derivados de benzotiazol
AR026163A1 (es) Utilizacion de retigabina para el tratamiento de dolores neuropaticos
ECSP055980A (es) Oxazolidinonas de indolona y derivados de las mismas
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
ATE418554T1 (de) 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
ES2421948T3 (es) Compuestos y composiciones para suministrar agentes activos
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
CO6321285A2 (es) Uso de 3,11b-cis- dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
BRPI0415203A (pt) pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios
SE9901077D0 (sv) Novel use
UY28313A1 (es) Nonadepsipeptidos acilados
PA8661701A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
ECSP034561A (es) Derivados puente de piperazina
DE60112960D1 (de) Kondensierte pyridoindolderivate